These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 22272912)

  • 21. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.
    Choy E; Ganeshalingam K; Semb AG; Szekanecz Z; Nurmohamed M
    Rheumatology (Oxford); 2014 Dec; 53(12):2143-54. PubMed ID: 24907149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
    Sanders S; Geraci SA
    J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis.
    Kang EH; Liao KP; Kim SC
    Curr Rheumatol Rep; 2018 May; 20(7):42. PubMed ID: 29846814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk factors in inflammatory arthritis.
    Mirjafari H; Al-Husain A; Bruce IN
    Curr Opin Lipidol; 2011 Aug; 22(4):296-301. PubMed ID: 21670670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Manifestations in Rheumatoid Arthritis.
    Sanghavi N; Ingrassia JP; Korem S; Ash J; Pan S; Wasserman A
    Cardiol Rev; 2024 Mar-Apr 01; 32(2):146-152. PubMed ID: 36729119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rheumatoid arthritis--a risk factor of ischemic heart disease].
    Hollan I; Mikkelsen K; Førre Ø
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3259-62. PubMed ID: 16327849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications.
    Pieringer H; Pichler M
    QJM; 2011 Jan; 104(1):13-26. PubMed ID: 21068083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation.
    Chen J; Norling LV; Cooper D
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice.
    Giles JT
    Best Pract Res Clin Rheumatol; 2015; 29(4-5):597-613. PubMed ID: 26697769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipid profile and cardiovascular risk in patients with rheumatoid arthritis: Effect of the disease and of drug therapy].
    Hansel B; Bruckert E
    Ann Endocrinol (Paris); 2010 Sep; 71(4):257-63. PubMed ID: 20416859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration.
    Guin A; Sinhamahapatra P; Misra S; Choudhury Mazumder SR; Chatterjee S; Ghosh A
    Biomed J; 2019 Dec; 42(6):394-402. PubMed ID: 31948603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid arthritis (RA) and cardiovascular disease.
    Blum A; Adawi M
    Autoimmun Rev; 2019 Jul; 18(7):679-690. PubMed ID: 31059840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular diseases in rheumatoid arthritis].
    Nakajima A
    Nihon Rinsho; 2016 Jun; 74(6):1012-6. PubMed ID: 27311194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.
    Full LE; Monaco C
    Cardiovasc Ther; 2011 Aug; 29(4):231-42. PubMed ID: 20553292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity.
    Ristić GG; Subota V; Lepić T; Stanisavljević D; Glišić B; Ristić AD; Petronijević M; Stefanović DZ
    PLoS One; 2015; 10(8):e0130462. PubMed ID: 26247590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis.
    Boyer JF; Cantagrel A; Constantin A
    Curr Vasc Pharmacol; 2008 Jul; 6(3):218-27. PubMed ID: 18673161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of cardiovascular disease risk in patients with rheumatoid arthritis.
    Ahmed O; Krishnamurthy V; Kaba RA; Tahir H
    Expert Opin Pharmacother; 2022 Jun; 23(8):947-958. PubMed ID: 35575484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of experimental accelerated atherosclerosis by chondroitin sulphate.
    Martínez-Calatrava MJ; Largo R; Herrero-Beaumont G
    Osteoarthritis Cartilage; 2010 Jun; 18 Suppl 1():S12-6. PubMed ID: 20399896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
    Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
    Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.